Absci (ABSI) Shares Outstanding (Weighted Average) (2020 - 2026)

Absci's (ABSI) quarterly Shares Outstanding (Weighted Average) came in at $153.0 million in Q1 2026, up 22.9% year-on-year from $124.5 million in Q1 2025, and up 11.83% quarter-over-quarter from $136.8 million in Q4 2025.

Absci (ABSI) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends

Absci has disclosed Shares Outstanding (Weighted Average) across 7 years of filings, most recently posting $153.0 million for Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $153.0 million, up 22.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $153.0 million (up 22.9% YoY), and the FY2025 annual result was $136.8 million, up 24.07% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $153.0 million for Q1 2026 at Absci, up from $136.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $153.0 million in Q1 2026 to a low of $90.3 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $99.4 million (2024), against an average of $107.8 million.
  • Across the five-year window, Shares Outstanding (Weighted Average) surged 431.64% in 2022 and gained 0.81% in 2023, its largest moves.
  • Absci's Shares Outstanding (Weighted Average) stood at $90.8 million in 2022, then increased by 1.3% to $92.0 million in 2023, then rose by 19.79% to $110.2 million in 2024, then gained by 24.07% to $136.8 million in 2025, then grew by 11.83% to $153.0 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $153.0 million (Q1 2026), $136.8 million (Q4 2025), and $132.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Absci 1.13 Bn 1.01 Bn - 152.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 152.96 Mn
Dec 31, 2025 136.78 Mn
Sep 30, 2025 132.11 Mn
Jun 30, 2025 127.59 Mn
Mar 31, 2025 124.46 Mn
Dec 31, 2024 110.24 Mn
Sep 30, 2024 113.61 Mn
Jun 30, 2024 106.16 Mn
Mar 31, 2024 99.39 Mn
Dec 31, 2023 92.03 Mn
Sep 30, 2023 91.84 Mn
Jun 30, 2023 91.83 Mn
Mar 31, 2023 91.48 Mn
Dec 31, 2022 90.85 Mn
Sep 30, 2022 91.11 Mn
Jun 30, 2022 90.47 Mn
Mar 31, 2022 90.27 Mn
Dec 31, 2021 49.69 Mn
Sep 30, 2021 36.18 Mn
Jun 30, 2021 17.31 Mn